Ds3 - Regorafenib in Metastatic Colorectal Cancer: Cost-Effectiveness Analysis Based on Propensity Score Weighted Cohort of Czech Registry

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.044
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy